title: Deficiencies in the reporting of VD and t(1/2) in the FDA approved chemotherapy drug inserts.
abstract: Since its release in 2006, the US Food and Drug Administration (FDA) final improved format for prescription drug labeling has revamped the comprehensiveness of drug inserts, including chemotherapy drugs. The chemotherapy drug "packets", retrieved via the FDA website and other accredited drug information reporting agencies such as the Physician Drug Reference (PDR), are practically the only available unbiased summary of information. One objective is to impartially evaluate the reporting of useful pharmacokinetic parameters, in particular, Volume of Distribution (V(D)) and elimination half-life (t(1/2)), in randomly selected FDA approved chemotherapy drug inserts. The web-accessible portable document format (PDF) files for 30 randomly selected chemotherapy drugs are subjected to detailed search and the two parameters of interest are tabulated. The knowledge of the two parameters is essential in directing patient care as well as for clinical research and since the completeness of the core FDA recommendations has been found deficient, a detailed explanation of the impact of such deficiencies is provided.
authors.affiliation: Department of Chemistry Wesley College, Dover, DE.
authors.forename: Malcolm J
authors.initials: MJ
authors.lastname: D'Souza
authors.forename: Ghada J
authors.initials: GJ
authors.lastname: Alabed